British Land (LON:BLND – Get Rating)‘s stock had its “underweight” rating reissued by research analysts at Barclays in a research report issued to clients and investors on Monday, Marketbeat Ratings reports. They currently have a GBX 500 ($6.25) target price on the stock. Barclays‘s target price points to a potential upside of 3.48% from the company’s previous close.
Several other research analysts also recently commented on BLND. Morgan Stanley reaffirmed an “equal weight” rating on shares of British Land in a research note on Friday, January 28th. Royal Bank of Canada reissued a “sector perform” rating and set a GBX 500 ($6.25) target price on shares of British Land in a research note on Tuesday, April 12th. Finally, JPMorgan Chase & Co. reissued an “overweight” rating and issued a GBX 650 ($8.12) price target on shares of British Land in a report on Wednesday, April 13th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of GBX 532.86 ($6.66).
LON BLND opened at GBX 483.20 ($6.04) on Monday. The stock’s 50-day moving average price is GBX 513.24 and its 200-day moving average price is GBX 522.27. The company has a quick ratio of 0.46, a current ratio of 0.63 and a debt-to-equity ratio of 43.10. British Land has a 52 week low of GBX 441.70 ($5.52) and a 52 week high of GBX 563.80 ($7.04). The company has a market capitalization of £4.48 billion and a P/E ratio of 65.35.
About British Land (Get Rating)
Our portfolio of high quality UK commercial property is focused on London Offices and Retail around the UK. We own or manage a portfolio valued at £13.7bn (British Land share: £10.3bn) as at 30 September 2020 making us one of Europe's largest listed real estate investment companies. Our strategy is to provide places which meet the needs of our customers and respond to changing lifestyles – Places People Prefer.
- Skechers Stock Can Be Bought on Pullbacks
- ChemoCentryx: A Biotech Stock Well Worth the Risk
- Nasdaq Stock is a Buy the (Deep) Dip Opportunity
- Three Stocks To Ride Out A Rough Market
- MarketBeat: Week in Review 5/2 – 5/6
Receive News & Ratings for British Land Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for British Land and related companies with MarketBeat.com's FREE daily email newsletter.